Skip to main content
SpringerLink
Log in

Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?

  • Letter
  • Published:
Science and Engineering Ethics Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  • De Miguel Beriain, I. (2017). Legal issues regarding gene editing at the beginning of life: An EU perspective. Regenerative Medicine, 12(6), 669–679.

    Article  Google Scholar 

  • Walton, D. (2016). The slippery slope argument in the ethical debate on genetic engineering of humans. Science and Engineering Ethics, 23(6), 1507–1528.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. G.I. Cátedra de Derecho y Genoma Humano, Departamento de Derecho Público, University of the Basque Country. UPV/EHU, 48940, Leioa, Spain

    Iñigo de Miguel Beriain

  2. IKERBASQUE, Basque Foundation for Science, Bilbao, Spain

    Iñigo de Miguel Beriain

Authors
  1. Iñigo de Miguel Beriain
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Iñigo de Miguel Beriain.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

de Miguel Beriain, I. Gene Editing and the Slippery Slope Argument: Should We Fix the Enhancement/Therapy Distinction as the Definitive Boundary?. Sci Eng Ethics 25, 1257–1258 (2019). https://doi.org/10.1007/s11948-018-0048-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11948-018-0048-y

Search

Navigation